Skip to main content
. 2017 Nov 15;46(Database issue):D1091–D1106. doi: 10.1093/nar/gkx1121

Table 1. Guide to PHARMACOLOGY database counts for targets, ligands and interactions from database release 2017.5.

GtoPdb 2016 GtoPdb 2018 (±2016) GtoImmuPdb 2018
A. Target class content. Human UniProtKB accession counts
7TM receptors* 395 395 (0) 86
Nuclear hormone receptors 48 48 (0) 6
Catalytic receptors 239 243 (+4) 107
Ligand-gated ion channels 84 81 (-3) 3
Voltage-gated ion channels 141 144 (+3) 17
Other ion channels 47 49 (+2) 0
Transporters 508 509 (+1) 5
Enzymes (all) 1164 1184 (+20) 134
Kinases 539 546 (+7) 79
Proteases 240 243 (+3) 32
Other proteins 135 174 (+39) 64
Total number of targets 2761 2834 (+73) 420**
B. Ligand category counts
Synthetic organics 5055 5807 (+752) 449
Metabolites 582 584 (+2) 23
Endogenous peptides 759 782 (+23) 176
Other peptides including synthetic peptides 1222 1297 (+75) 37
Natural products 234 247 (+13) 9
Antibodies 138 223 (+85) 121
Inorganics 34 38 (+4) 1
Approved drugs 1233 1334 (+101) 208
Withdrawn drugs 67 67 (0) 11
Ligands with INNs 1882 2114 (+232) 336
PubChem CIDs 6037 6702 (+665) 484
PubChem SIDs 8024 8978 (+954) 816
Total number of ligands 8024 8978 (+954) 816
C. Interaction counts
Human targets with ligand interactions 1505 1684 (+179) 390
Human targets with quantitative ligand interactions 1228 1431 (+203) 321
Human targets with approved drug interactions 554 563 (+9) 152
Primary targets*** with approved drug interactions 312 313 (+1) 91
Ligands with target interactions 6796 7663 (+867) 718
Ligands with quantitative interactions (approved drugs) 5860 6716 (+856) 553
738 824 (+86) 138
Ligands with clinical use summaries (approved drugs) 1724 2089 (+365) 423
1231 1332 (+101) 208
Number of binding constants 44 691 46 488 (+1797) 23 304
Number of binding constants curated from the literature 13 484 15 281 (+1797) 10 964
References 27 880 31 733 (+3933)

* Not all the 7TM receptor records are unequivocally assigned as GPCRs, but for convenience we refer to these generally as GPCRs in the text.

** Thirty-five targets are tagged in GtoImmuPdb but have no Human UniProtKB accession. Thirty-four of these are complexes (only subunits have UniProtKB accessions, and 1 that only has a mouse accession).

*** Primary target indicates the dominant Molecular Mechanism of Action (MMOA)

**** An interaction is only considered part of GtoImmuPdb where both the target and ligand are tagged as relevant to immunopharmacology. The table shows just under one quarter of all the curated interactions in GtoPdb involve targets and ligands of immunological relevance (we are still in the process of identifying these so it is likely to increase).

The table includes a comparison to the figures from the 2016 update (5), and a breakdown for the GtoImmuPdb dataset. Categories are not mutually exclusive and targets and ligands can fall into more than one, therefore totals are not the sum of all other rows.